Abstract
CP-28,888-27 and placebo nasal sprays were compared in 62 normal volunteers challenged with rhinovirus type 13 or 21 in two randomized, double-blind studies. Half of the subjects received CP-28,888-27 and half received nasal placebo administered at 24, 20, and 16 h before challenge and 4 and 8 h after challenge. In each study, the number of subjects shedding virus in nasal washes, the number developing fourfold or greater serum antibody responses, and the number developing afebrile or febrile upper respiratory tract illness were not significantly different comparing subjects given CP-28,888-27 and those given placebo. Interferon was detected in nasal washes from 5 of 15 volunteers tested in the CP-28,888-27 group compared to 2 of 15 volunteers from the placebo group.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Douglas R. G., Jr, Betts R. F. Effect of induced interferon in experimental rhinovirus infections in volunteers. Infect Immun. 1974 Mar;9(3):506–510. doi: 10.1128/iai.9.3.506-510.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Douglas R. G., Jr, Betts R. F., Simons R. L., Hogan P. W., Roth F. K. Evaluation of a topical interferon inducer in experimental influenza infection in volunteers. Antimicrob Agents Chemother. 1975 Dec;8(6):684–687. doi: 10.1128/aac.8.6.684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gatmaitan B. C., Stanley E. D., Jackson G. G. The limited effect of nasal interferon induced by rhinovirus and a topical chemical inducer on the course of infection. J Infect Dis. 1973 Apr;127(4):401–407. doi: 10.1093/infdis/127.4.401. [DOI] [PubMed] [Google Scholar]
- Hill D. A., Baron S., Chanock R. M. Sensitivity of common respiratory viruses to an interferon inducer in human cells. Lancet. 1969 Jul 26;2(7613):187–188. doi: 10.1016/s0140-6736(69)91425-1. [DOI] [PubMed] [Google Scholar]
- Hill D. A., Baron S., Perkins J. C., Worthington M., Van Kirk J. E., Mills J., Kapikian A. Z., Chanock R. M. Evaluation of an interferon inducer in viral respiratory disease. JAMA. 1972 Feb 28;219(9):1179–1184. [PubMed] [Google Scholar]
- Hoffman W. W., Korst J. J., Niblack J. F., Cronin T. H. N,N-dioctadecyl-N',N'-bis(2-hydroxyethyl) propanediamine: antiviral activity and interferon stimulation in mice. Antimicrob Agents Chemother. 1973 Apr;3(4):498–502. doi: 10.1128/aac.3.4.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KNIGHT V. THE USE OF VOLUNTEERS IN MEDICAL VIROLOGY. Prog Med Virol. 1964;6:1–26. [PubMed] [Google Scholar]
- Merigan T. C., Reed S. E., Hall T. S., Tyrrell D. A. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973 Mar 17;1(7803):563–567. doi: 10.1016/s0140-6736(73)90714-9. [DOI] [PubMed] [Google Scholar]
- Niblack J. F. Studies with low molecular weight inducers of interferon in man. Tex Rep Biol Med. 1977;35:528–534. [PubMed] [Google Scholar]
- PETRALLI J. K., MERIGAN T. C., WILBUR J. R. ACTION OF ENDOGENOUS INTERFERON AGAINST VACCINIA INFECTION IN CHILDREN. Lancet. 1965 Aug 28;2(7409):401–405. doi: 10.1016/s0140-6736(65)90755-5. [DOI] [PubMed] [Google Scholar]
- Panusarn C., Stanley E. D., Dirda V., Rubenis M., Jackson G. G. Prevention of illness from rhinovirus infection by a topical interferon inducer. N Engl J Med. 1974 Jun 11;291(2):57–61. doi: 10.1056/NEJM197407112910201. [DOI] [PubMed] [Google Scholar]
- Stanley E. D., Jackson G. G., Dirda V. A., Rubenis M. Effect of a topical interferon inducer on rhinovirus infections in volunteers. J Infect Dis. 1976 Jun;133 (Suppl):A121–A127. doi: 10.1093/infdis/133.supplement_2.a121. [DOI] [PubMed] [Google Scholar]